Cargo Therapeutics
PrivateLast Round
M&A
Aug 19, 2025
Est. Valuation
$211.8M
Total Funding Raised
$243M
Company Overview
Cargo Therapeutics operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Private Placement round in May 2024.
Cargo Therapeutics is a biotechnology company focused on developing next-generation, potentially curative cell therapies for cancer patients, utilizing innovative programs and manufacturing strategies to overcome the limitations of existing treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cargo Therapeutics Comparables
Compare Cargo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Umoja Biopharma | 77% | |
| Cellectis | 76% | |
| Sana Biotechnology | 76% |
For institutional investors. Book with your work email.
Cargo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 19, 2025 | ||||
| Private Placement | May 28, 2024 | ||||
| IPO | Nov 9, 2023 | ||||
| Series A | Mar 1, 2023 | ||||
| Convertible Debt | Jan 1, 2023 | ||||
Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Cargo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Private Placement |
| Jefferies | IPO |
| Janus Henderson Group | Series A |
| Perceptive Advisors | Private Placement, Series A |
| Ally Bridge Group | Series A, Private Placement |
| Heartland Healthcare Capital | Series A |
| Xontogeny | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2024
$110M round with participation from T. Rowe Price and Wellington Management.
- Mar 1, 2023
$200M round led by Perceptive Advisors and Third Rock Ventures.
For institutional investors. Book with your work email.
Cargo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cargo Therapeutics's valuation, stock price, and market status.
Is Cargo Therapeutics a public or private company?
Cargo Therapeutics is a private company.
What is the current stock price of Cargo Therapeutics?
Cargo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cargo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cargo Therapeutics worth (valuation)?
Cargo Therapeutics's valuation is estimated at $211.8M based on funding round data.
Can I buy Cargo Therapeutics stock?
Cargo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cargo Therapeutics's last funding round?
Cargo Therapeutics's most recent funding round was M&A on August 19, 2025.
Who are the main investors in Cargo Therapeutics?
Key investors in Cargo Therapeutics include Jefferies, Perceptive Advisors, Xontogeny, TD Cowen, Truist Securities.
Will Cargo Therapeutics IPO soon?
No public IPO plans have been announced for Cargo Therapeutics.
How can I track Cargo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cargo Therapeutics's shares on secondary markets.